Topics

New DNA “Fingerprint” Test Predicts Response To Toxic Breast Cancer Drugs

11:00 EST 7 Nov 2019 | Forbes

Scientists have developed a new genetic fingerprint test which aims to identify women with breast cancer who are likely to respond to a class of often-useful, but toxic chemotherapy agents including one commonly referred to as "the red devil" by patients and survivors.

Original Article: New DNA “Fingerprint” Test Predicts Response To Toxic Breast Cancer Drugs

NEXT ARTICLE

More From BioPortfolio on "New DNA “Fingerprint” Test Predicts Response To Toxic Breast Cancer Drugs"

Quick Search

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...